Complete Tirzepatide Guide

    Information about tirzepatide, the medication in the prescription brands Zepbound and Mounjaro, including dosing, side effects and questions to discuss with a licensed provider.

    Brand-drug trial evidence

    In SURMOUNT-1, participants receiving the highest studied dose of tirzepatide, 15 mg weekly, had a mean body-weight reduction of 20.9% at 72 weeks. This was a trial of the brand drug, not compounded tirzepatide; it does not establish an outcome for compounded tirzepatide.

    Mechanism

    Tirzepatide acts at GIP and GLP-1 receptors.

    Once-Weekly Injection

    Convenient dosing schedule that fits seamlessly into your routine

    Comprehensive Resource Library

    Explore our expertly curated guides covering every aspect of tirzepatide treatment.

    Cost & Affordability

    Complete breakdown of tirzepatide costs, insurance coverage options, and strategies for affordable access.

    • Tirzepatide pricing guide
    • Insurance coverage strategies
    • Mounjaro vs Zepbound costs
    • Savings programs availability
    Explore Cost & Affordability

    Getting Started

    Everything you need to begin tirzepatide treatment, from eligibility to your first injection.

    • Tirzepatide eligibility
    • Starting tirzepatide guide
    • First month expectations
    • Provider selection tips
    Explore Getting Started

    Dosage & Administration

    Master tirzepatide dosing schedules, proper injection technique, and administration guidelines.

    • Tirzepatide dosing schedule
    • Dose escalation protocol
    • Injection best practices
    • Managing dose adjustments
    Explore Dosage & Administration

    Side Effects Management

    Learn to identify, manage, and minimize side effects for optimal comfort during treatment.

    • Common side effects
    • Gastrointestinal management
    • Dietary adjustments
    • Safety monitoring
    Explore Side Effects Management

    Results & Effectiveness

    Understand realistic expectations, timelines, and strategies for maximizing weight loss results.

    • Weight loss expectations
    • Clinical trial results
    • Long-term outcomes
    • Success optimization
    Explore Results & Effectiveness

    Comparisons

    Compare tirzepatide with semaglutide and other treatments to make informed decisions.

    • Tirzepatide vs Semaglutide
    • Mounjaro vs Zepbound
    • Dual-action benefits
    • Effectiveness comparison
    Explore Comparisons

    What is Tirzepatide?

    Tirzepatide acts at GIP and GLP-1 receptors. Zepbound is a prescription brand used for weight management, and Mounjaro is a prescription brand used for type 2 diabetes. Compounded tirzepatide is not either brand and is not FDA-approved.

    In SURMOUNT-1, participants receiving the highest studied dose of tirzepatide, 15 mg weekly, had a mean body-weight reduction of 20.9% at 72 weeks. This was a trial of the brand drug, not compounded tirzepatide; it does not establish an outcome for compounded tirzepatide.

    Zepbound is FDA-approved, alongside a reduced-calorie diet and increased physical activity, to reduce excess weight and maintain weight reduction in adults with obesity, or adults with overweight and at least one weight-related condition. This approval applies to Zepbound, not compounded tirzepatide. A licensed provider decides whether a treatment is appropriate.

    Ready to Start Your Tirzepatide Journey?

    Discuss your medical history, treatment options and questions with a licensed provider.